Aryl hydrocarbon receptor: Linking environment to immunity

Seminars in Immunology

Volumn 27, Issue 5, 2015, Pages 310-314

  Cella, Marina ^a   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aryl hydrocarbon receptor; IL 22; Innate lymphoid cells; Mucosal tissues

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 INDOLEMETHANOL; APIGENIN; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CHRYSIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DIOXIN; GALANGIN; GAMMA INTERFERON; GENISTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 27; INTERLEUKIN 6; KYNURENINE; NAPHTHOQUINONE; PATTERN RECOGNITION RECEPTOR; QUERCETIN; RESVERATROL; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TRYPTOPHAN DERIVATIVE; LIGAND;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTACT ALLERGY; CYTOKINE PRODUCTION; DENDRITIC CELL; FATTY LIVER; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOID CELL; MUCOSAL IMMUNITY; NONHUMAN; PSORIASIS; REVIEW; TH17 CELL; ANIMAL; ANTIBODY SPECIFICITY; ENVIRONMENT; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; DENDRITIC CELLS; ENVIRONMENT; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNITY, INNATE; LIGANDS; LYMPHOCYTE SUBSETS; ORGAN SPECIFICITY; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 84951866819     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.10.002     Document Type: Review

References (81)

1. Kewley R.J., Whitelaw M.L., Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 2004, 36:189-204.
2. Gu Y.Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Ann. Rev. Pharmacol. Toxicol. 2000, 40:519-561.
3. Nambu J.R., Lewis J.O., Wharton K.A., Crews S.T. The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell 1991, 67:1157-1167.
4. Burbach K.M., Poland A., Bradfield C.A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:8185-8189.
5. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
6. Warner M., Mocarelli P., Brambilla P., Wesselink A., Patterson D.G., Turner W.E., et al. Serum TCDD and TEQ concentrations among Seveso women, 20 years after the explosion. J. Exp. Sci. Env. Epidem. 2014, 24:588-594.
7. Nguyen L.P., Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 2008, 21:102-116.
8. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:9543-9547.
9. Zhang S., Qin C., Safe S.H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Env. Health Persp. 2003, 111:1877-1882.
10. Hu Q., He G., Zhao J., Soshilov A., Denison M.S., Zhang A., et al. Ginsenosides are novel naturally-occurring aryl hydrocarbon receptor ligands. PloS One 2013, 8:e66258.
11. Rannug U., Rannug A., Sjoberg U., Li H., Westerholm R., Bergman J. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem & Biol. 1995, 2:841-845.
12. Mezrich J.D., Fechner J.H., Zhang X., Johnson B.P., Burlingham W.J., Bradfield C.A. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 2010, 185:3190-3198.
13. Sarsero J.P., Merino E., Yanofsky C. A Bacillus subtilis operon containing genes of unknown function senses tRNATrp charging and regulates expression of the genes of tryptophan biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2656-2661.
14. Gaitanis G., Magiatis P., Stathopoulou K., Bassukas I.D., Alexopoulos E.C., Velegraki A., et al. AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J. Inv. Dermatol. 2008, 128:1620-1625.
15. Takamura T., Harama D., Fukumoto S., Nakamura Y., Shimokawa N., Ishimaru K., et al. Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis. Immunol. Cell Biol. 2011, 89:817-822.
16. Zelante T., Iannitti R.G., Cunha C., De Luca A., Giovannini G., Pieraccini G., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39:372-385.
17. Moura-Alves P., Fae K., Houthuys E., Dorhoi A., Kreuchwig A., Furkert J., et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 2014, 512:387-392.
18. Esser C., Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 2015, 67:259-279.
19. Di Meglio P., Duarte J.H., Ahlfors H., Owens N.D., Li Y., Villanova F., et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 2014, 40:989-1001.
20. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268:722-726.
21. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., Bradfield C.A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6731-6736.
22. Andreola F., Fernandez-Salguero P.M., Chiantore M.V., Petkovich M.P., Gonzalez F.J., De Luca L.M. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 1997, 57:2835-2838.
23. Hauben E., Gregori S., Draghici E., Migliavacca B., Olivieri S., Woisetschlager M., et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008, 112:1214-1222.
24. Lawrence B.P., Denison M.S., Novak H., Vorderstrasse B.A., Harrer N., Neruda W., et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008, 112:1158-1165.
25. Platzer B., Richter S., Kneidinger D., Waltenberger D., Woisetschlager M., Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 2009, 183:66-74.
26. Boitano A.E., Wang J., Romeo R., Bouchez L.C., Parker A.E., Sutton S.E., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348.
27. Liu H., Ramachandran I., Gabrilovich D.I. Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor. Immunol. Cell Biol. 2014, 92:200-203.
28. Thordardottir S., Hangalapura B.N., Hutten T., Cossu M., Spanholtz J., Schaap N., et al. The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells. Stem Cell Dev. 2014, 23:955-967.
29. Jux B., Kadow S., Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J. Immunol. 2009, 182:6709-6717.
30. Vogel C.F., Goth S.R., Dong B., Pessah I.N., Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 2008, 375:331-335.
31. Nguyen N.T., Kimura A., Nakahama T., Chinen I., Masuda K., Nohara K., et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19961-19966.
32. Song J., Clagett-Dame M., Peterson R.E., Hahn M.E., Westler W.M., Sicinski R.R., et al. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14694-14699.
33. Quintana F.J., Murugaiyan G., Farez M.F., Mitsdoerffer M., Tukpah A.M., Burns E.J., et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20768-20773.
34. Vogel C.F., Khan E.M., Leung P.S., Gershwin M.E., Chang W.L., Wu D., et al. Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-kappaB. J. Biol. Chem. 2014, 289:1866-1875.
35. Kimura A., Naka T., Nakahama T., Chinen I., Masuda K., Nohara K., et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 2009, 206:2027-2035.
36. Bessede A., Gargaro M., Pallotta M.T., Matino D., Servillo G., Brunacci C., et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 2014, 511:184-190.
37. Opitz C.A., Litzenburger U.M., Sahm F., Ott M., Tritschler I., Trump S., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011, 478:197-203.
38. Pilotte L., Larrieu P., Stroobant V., Colau D., Dolusic E., Frederick R., et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2497-2502.
39. Funatake C.J., Marshall N.B., Steppan L.B., Mourich D.V., Kerkvliet N.I. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells. J. Immunol. 2005, 175:4184-4188.
40. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
41. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
42. Veldhoen M., Hirota K., Christensen J., O'Garra A., Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 2009, 206:43-49.
43. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9721-9726.
44. Rutz S., Noubade R., Eidenschenk C., Ota N., Zeng W., Zheng Y., et al. Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells. Nat. Immunol. 2011, 12:1238-1245.
45. Alam M.S., Maekawa Y., Kitamura A., Tanigaki K., Yoshimoto T., Kishihara K., et al. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5943-5948.
46. Qiu J., Guo X., Chen Z.M., He L., Sonnenberg G.F., Artis D., et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 2013, 39:386-399.
47. Guo X., Liang Y., Zhang Y., Lasorella A., Kee B.L., Fu Y.X. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity 2015, 42:731-743.
48. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
49. Yang Y., Torchinsky M.B., Gobert M., Xiong H., Xu M., Linehan J.L., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 2014, 510:152-156.
50. Goto Y., Panea C., Nakato G., Cebula A., Lee C., Diez M.G., et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 2014, 40:594-607.
51. Apetoh L., Quintana F.J., Pot C., Joller N., Xiao S., Kumar D., et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 2010, 11:854-861.
52. Wu H.Y., Quintana F.J., da Cunha A.P., Dake B.T., Koeglsperger T., Starossom S.C., et al. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PloS One 2011, 6:e23618.
53. Gandhi R., Kumar D., Burns E.J., Nadeau M., Dake B., Laroni A., et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 2010, 11:846-853.
54. Quintana F.J., Jin H., Burns E.J., Nadeau M., Yeste A., Kumar D., et al. Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 2012, 13:770-777.
55. Gagliani N., Vesely M.C., Iseppon A., Brockmann L., Xu H., Palm N.W., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015, 523:221-225.
56. Mascanfroni I.D., Takenaka M.C., Yeste A., Patel B., Wu Y., Kenison J.E., et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 2015, 21:638-646.
57. Basu R., O'Quinn D.B., Silberger D.J., Schoeb T.R., Fouser L., Ouyang W., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
58. Ramirez J.M., Brembilla N.C., Sorg O., Chicheportiche R., Matthes T., Dayer J.M., et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur. J. Immunol. 2010, 40:2450-2459.
59. Lawrence B.P., Roberts A.D., Neumiller J.J., Cundiff J.A., Woodland D.L. Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T cells in the lung. J. Immunol. 2006, 177:5819-5828.
60. Winans B., Nagari A., Chae M., Post C.M., Ko C.I., Puga A., et al. Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T cell responses. J. Immunol. 2015, 194:4446-4457.
61. Zaid A., Mackay L.K., Rahimpour A., Braun A., Veldhoen M., Carbone F.R., et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:5307-5312.
62. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 2006, 177:4662-4669.
63. Duan J., Chung H., Troy E., Kasper D.L. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe 2010, 7:140-150.
64. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
65. Li Y., Innocentin S., Withers D.R., Roberts N.A., Gallagher A.R., Grigorieva E.F., et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147:629-640.
66. Kadow S., Jux B., Zahner S.P., Wingerath B., Chmill S., Clausen B.E., et al. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis. J. Immunol. 2011, 187:3104-3110.
67. Guo L., Junttila I.S., Paul W.E. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol. 2012, 33:598-606.
68. Cella M., Miller H., Song C. Beyond NK cells: the expanding universe of innate lymphoid cells. Front. Immunol. 2014, 5:282-292.
69. Diefenbach A., Colonna M., Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014, 41:354-365.
70. Eberl G., Colonna M., Di Santo J.P., McKenzie A.N. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science 2015, 348:aaa6566.
71. Artis D., Spits H. The biology of innate lymphoid cells. Nature 2015, 517:293-301.
72. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
73. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
74. Qiu J., Heller J.J., Guo X., Chen Z.M., Fish K., Fu Y.X., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
75. Hughes T., Briercheck E.L., Freud A.G., Trotta R., McClory S., Scoville S.D., et al. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep. 2014, 8:150-162.
76. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10961-10966.
77. Bouskra D., Brezillon C., Berard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
78. Shin J.H., Zhang L., Murillo-Sauca O., Kim J., Kohrt H.E., Bui J.D., et al. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:12391-12396.
79. Wagage S., John B., Krock B.L., Hall A.O., Randall L.M., Karp C.L., et al. The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J. Immunol. 2014, 192:1661-1670.
80. Kamanaka M., Huber S., Zenewicz L.A., Gagliani N., Rathinam C., O'Connor W., et al. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 2011, 208:1027-1040.
81. Kirchberger S., Royston D.J., Boulard O., Thornton E., Franchini F., Szabady R.L., et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 2013, 210:917-931.